FDA Issues Warning Over Kardashian's Instagramming

If Kim Kardashian is going to promote drugs, she needs to talk about their side effects as well as their benefits, the FDA has warned a pharmaceutical company. Duchesnay, maker of the morning-sickness pill Diclegis, has received a formal warning from the regulator over Facebook and Instagram posts in which the reality star praised the drug, NBC News reports. The FDA says the "false and misleading" posts fail to "communicate any risk information," including the fact that side effects can include dizziness and sleeplessness and that it's not recommended for women suffering from prolonged vomiting, reports USA Today.

Kardashian is pregnant with her second child and says her morning sickness was "pretty bad" before using the drug. The reason the FDA got involved is because she wasn't "just a happy celebrity sharing her health tips with her 464,000 closest friends," as David Kroll at Forbes puts it, but had been paid by Duchesnay to promote the drug. The offending posts have been deleted and the FDA says "corrective messaging should be distributed using the same media," which means Kardashian's millions of followers may soon be hearing about the side effects of Diclegis, NBC notes. (Kardashian posted a very revealing naked selfie yesterday to dispel rumors that she isn't really pregnant.)